Cefdinir-Associated “Bloody Stools” in an Infant

References

1. ↵
   Omnicef package insert. Chicago, IL: Abbott Laboratories. July 2005.
2. ↵
   Naranjo CA, Busto J, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239–45.

   OpenUrlPubMedWeb of Science
3. ↵
   Nelson JS. Red stools and Omnicef. J Pediatr 2000; 136: 853–4.

   OpenUrlPubMed
4. ↵
   Cefdinir: red stools in a child and an infant: 2 case reports. Reactions 2000; 1: 6.

   OpenUrl
5. ↵
   Nelson JD, McCracken GH. Red stools and Omnicef. Ped Infect Dis J 2002; 21: A7–A8.

   OpenUrl
6. ↵
   Bowlware KL, McCracken GH, Lozano-Hernandez J, Ghaffar F. Cefdinir pharmacokinetics and tolerability in children receiving 25mg/kg once daily. Ped Infect Dis J 2006; 25: 208–10.

   OpenUrl
7. ↵
   Gilbert DN, Moellering RC, Eliopoulos GM, Sande MA. The Sanford Guide to Antimicrobial Therapy 2007. 37th edition. Sperryville (VA): Antimicrobial Therapy, Inc.; 2007: 87.